Cargando…

Learning from remote decentralised clinical trial experiences: A qualitative analysis of interviews with trial personnel, patient representatives and other stakeholders

AIMS: The aim of the study was to identify actionable learning points from stakeholders in remote decentralised clinical trials (RDCTs) to inform their future design and conduct. METHODS: Semistructured interviews were carried out with a purposive sample of stakeholders, including senior managers, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Coyle, Joanne, Rogers, Amy, Copland, Rachel, De Paoli, Giorgia, MacDonald, Thomas M., Mackenzie, Isla S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290051/
https://www.ncbi.nlm.nih.gov/pubmed/34296777
http://dx.doi.org/10.1111/bcp.15003
_version_ 1784748798573019136
author Coyle, Joanne
Rogers, Amy
Copland, Rachel
De Paoli, Giorgia
MacDonald, Thomas M.
Mackenzie, Isla S.
author_facet Coyle, Joanne
Rogers, Amy
Copland, Rachel
De Paoli, Giorgia
MacDonald, Thomas M.
Mackenzie, Isla S.
author_sort Coyle, Joanne
collection PubMed
description AIMS: The aim of the study was to identify actionable learning points from stakeholders in remote decentralised clinical trials (RDCTs) to inform their future design and conduct. METHODS: Semistructured interviews were carried out with a purposive sample of stakeholders, including senior managers, trial managers, technology experts, principal investigators, clinical investigators, research scientists, research nurses, vendors, patient representatives and project assistants. The interview data were coded using a thematic approach, identifying similarities, differences and clustering to generate descriptive themes. Further refinement of themes was guided by empirical phenomenology, grounding explanation in the meanings that interviewees gave to their experiences. RESULTS: Forty‐eight stakeholders were interviewed. Actionable learning points were generated from the thematic analysis. Patient involvement and participant engagement were seen as critical to the success of RDCTs where in‐person contact is minimal or nonexistent. Involving patients in identifying the research question, creating recruitment materials, apps and websites, and providing ongoing feedback to trial participants were regarded as facilitating recruitment and engagement. Building strong relationships early with trial partners was thought to support RDCT conduct. Multiple modes of capturing information, including patient‐reported outcomes (PROs) and routinely collected data, were felt to contribute to data completeness. However, RDCTs may transfer trial activity burden onto participants and remote‐working research staff, therefore additional support may be needed. CONCLUSION: RDCTs will continue to face challenges in implementing novel technologies. However, maximising patient and partner involvement, reducing participant and staff burden, and simplifying how participants and staff interact with the RDCT may facilitate their implementation.
format Online
Article
Text
id pubmed-9290051
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-92900512022-07-20 Learning from remote decentralised clinical trial experiences: A qualitative analysis of interviews with trial personnel, patient representatives and other stakeholders Coyle, Joanne Rogers, Amy Copland, Rachel De Paoli, Giorgia MacDonald, Thomas M. Mackenzie, Isla S. Br J Clin Pharmacol Original Articles AIMS: The aim of the study was to identify actionable learning points from stakeholders in remote decentralised clinical trials (RDCTs) to inform their future design and conduct. METHODS: Semistructured interviews were carried out with a purposive sample of stakeholders, including senior managers, trial managers, technology experts, principal investigators, clinical investigators, research scientists, research nurses, vendors, patient representatives and project assistants. The interview data were coded using a thematic approach, identifying similarities, differences and clustering to generate descriptive themes. Further refinement of themes was guided by empirical phenomenology, grounding explanation in the meanings that interviewees gave to their experiences. RESULTS: Forty‐eight stakeholders were interviewed. Actionable learning points were generated from the thematic analysis. Patient involvement and participant engagement were seen as critical to the success of RDCTs where in‐person contact is minimal or nonexistent. Involving patients in identifying the research question, creating recruitment materials, apps and websites, and providing ongoing feedback to trial participants were regarded as facilitating recruitment and engagement. Building strong relationships early with trial partners was thought to support RDCT conduct. Multiple modes of capturing information, including patient‐reported outcomes (PROs) and routinely collected data, were felt to contribute to data completeness. However, RDCTs may transfer trial activity burden onto participants and remote‐working research staff, therefore additional support may be needed. CONCLUSION: RDCTs will continue to face challenges in implementing novel technologies. However, maximising patient and partner involvement, reducing participant and staff burden, and simplifying how participants and staff interact with the RDCT may facilitate their implementation. John Wiley and Sons Inc. 2021-08-12 2022-03 /pmc/articles/PMC9290051/ /pubmed/34296777 http://dx.doi.org/10.1111/bcp.15003 Text en © 2021 The Authors. British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles
Coyle, Joanne
Rogers, Amy
Copland, Rachel
De Paoli, Giorgia
MacDonald, Thomas M.
Mackenzie, Isla S.
Learning from remote decentralised clinical trial experiences: A qualitative analysis of interviews with trial personnel, patient representatives and other stakeholders
title Learning from remote decentralised clinical trial experiences: A qualitative analysis of interviews with trial personnel, patient representatives and other stakeholders
title_full Learning from remote decentralised clinical trial experiences: A qualitative analysis of interviews with trial personnel, patient representatives and other stakeholders
title_fullStr Learning from remote decentralised clinical trial experiences: A qualitative analysis of interviews with trial personnel, patient representatives and other stakeholders
title_full_unstemmed Learning from remote decentralised clinical trial experiences: A qualitative analysis of interviews with trial personnel, patient representatives and other stakeholders
title_short Learning from remote decentralised clinical trial experiences: A qualitative analysis of interviews with trial personnel, patient representatives and other stakeholders
title_sort learning from remote decentralised clinical trial experiences: a qualitative analysis of interviews with trial personnel, patient representatives and other stakeholders
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290051/
https://www.ncbi.nlm.nih.gov/pubmed/34296777
http://dx.doi.org/10.1111/bcp.15003
work_keys_str_mv AT coylejoanne learningfromremotedecentralisedclinicaltrialexperiencesaqualitativeanalysisofinterviewswithtrialpersonnelpatientrepresentativesandotherstakeholders
AT rogersamy learningfromremotedecentralisedclinicaltrialexperiencesaqualitativeanalysisofinterviewswithtrialpersonnelpatientrepresentativesandotherstakeholders
AT coplandrachel learningfromremotedecentralisedclinicaltrialexperiencesaqualitativeanalysisofinterviewswithtrialpersonnelpatientrepresentativesandotherstakeholders
AT depaoligiorgia learningfromremotedecentralisedclinicaltrialexperiencesaqualitativeanalysisofinterviewswithtrialpersonnelpatientrepresentativesandotherstakeholders
AT macdonaldthomasm learningfromremotedecentralisedclinicaltrialexperiencesaqualitativeanalysisofinterviewswithtrialpersonnelpatientrepresentativesandotherstakeholders
AT mackenzieislas learningfromremotedecentralisedclinicaltrialexperiencesaqualitativeanalysisofinterviewswithtrialpersonnelpatientrepresentativesandotherstakeholders
AT learningfromremotedecentralisedclinicaltrialexperiencesaqualitativeanalysisofinterviewswithtrialpersonnelpatientrepresentativesandotherstakeholders